FdaApplication

ANDA 211361

Back to search

Identifiers

Properties

PropertyValue
applicant_nameJUBILANT GENERICS LTD
application_typeANDA
approval_date2025-04-15

Products (2)

ProductActive ingredientStrengthDosage form
RANOLAZINERANOLAZINE500MGTABLET, EXTENDED RELEASE;ORAL
RANOLAZINERANOLAZINE1GMTABLET, EXTENDED RELEASE;ORAL

2 products